Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer.

Justin Jee,Emily S. Lebow,Yonina R. Murciano-Goroff,Gowtham Jayakumaran,Ronglai Shen,Angela Rose Brannon,Ryma Benayed,Azadeh Namakydoust,Michael Offin,Paul K. Paik,Helena Alexandra Yu,Mark T.A. Donoghue,Ahmet Zehir,Alexander Drilon,David B. Solit,David R. Jones,Charles M. Rudin,Michael F. Berger,James M. Isbell,Bob T. Li

Overall survival with circulating tumor DNA-guided therapy in advanced non-small cell lung cancer.

2021

9009Background: The effectiveness of circulating tumor DNA (ctDNA) at matching patients to life prolonging therapy has been studied mostly in small cohorts with limited follow up. The prognostic va...

Keywords:

Medicine
Oncology
overall survival
Circulating tumor DNA
Lung cancer
non small cell
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations